Wexford Capital’s Pelthos Therapeutics PTHS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.78M Buy
84,616
+62,252
+278% +$1.59M 0.23% 43
2026
Q2
$632K Buy
+22,364
New +$574K 0.08% 90

Other funds holding PTHS

Wexford Capital's PTHS Position: Q3 2026 in Review

Wexford Capital increased its Pelthos Therapeutics (PTHS) stake by 278% in Q3 2026, buying an estimated $1.59M and bringing the position to 84,616 shares worth $1.78M. The position accounts for 0.23% of the portfolio, ranked #43.

Wexford Capital first reported a position in PTHS in Q2 2026 and has held it in 2 quarters since. 29 funds tracked by Wall St. Rank hold PTHS as of Q3 2026.

  • Wexford Capital held 84,616 shares of Pelthos Therapeutics worth $1.78M as of Q3 2026.
  • Wexford Capital bought 62,252 Pelthos Therapeutics shares in Q3 2026, an estimated $1.59M.
  • Pelthos Therapeutics made up 0.23% of Wexford Capital's portfolio in Q3 2026, its #43 holding.
  • Wexford Capital first reported a position in Pelthos Therapeutics in Q2 2026 and has held it in 2 quarters since.
  • 29 funds tracked by Wall St. Rank held Pelthos Therapeutics as of Q3 2026.

Based on Wexford Capital's 13F filing for Q3 2026, filed 13 Nov 2026.